Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeutic and commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.

Operations

Quality Assurance

Vancouver, BC, Canada

North Vancouver, BC, Canada

Abdera Therapeutics

Amplitude Ventures Inc.

Amplitude Ventures

Discover opportunities across our network of transformational companies

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Amplitudevc Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Amplitudevc network as they come up.

You can always update this information later.

Welcome to the Amplitudevc talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Amplitudevc company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Portfolio Careers